BRADFORD WITMAN: Open Payments
NPI 1316198393 · GOLDEN, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 22 payments from 10 companies in 2025. Trend: 2023 $877 · 2024 $725 · 2025 $502
Food & beverage: $502
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $142 |
| Teva Pharmaceuticals USA, Inc. | 4 | $74 |
| ABBVIE INC. | 2 | $55 |
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
| Alkermes, Inc. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Lundbeck LLC | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Indivior Inc. | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
Products named: REXULTI, AUSTEDO XR, VRAYLAR, COBENFY, CAPLYTA, INGREZZA, VIVITROL, SUBLOCADE.
Industry payments across CO — which companies pay providers there.
